|
Aug 8
|
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
|
|
Aug 8
|
Epkinly breaks ground in Phase III FL trial
|
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
|
Aug 7
|
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
|
|
Aug 7
|
REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
|
|
Aug 7
|
REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy
|
|
Aug 6
|
Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
|
|
Aug 6
|
Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi
|
|
Aug 6
|
Get Ready, JUVÉDERM® Day is Calling!
|
|
Aug 6
|
Hungary's Richter says some US exports face tariff challenges, but flagship drug exempt
|
|
Aug 5
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Aug 5
|
AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?
|
|
Aug 5
|
AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 5
|
Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency
|
|
Aug 5
|
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
|
|
Aug 4
|
Pharma CEOs downplay impact of tariffs amid rising cost concerns
|
|
Aug 4
|
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
|
|
Aug 4
|
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
|
|
Aug 3
|
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
|
|
Aug 3
|
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
|